ANI Pharmaceuticals Inc (ANIP) stock
ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3054% below fair value
$71.44+0.38 (+0.53%)
Close on Nov 13, 2026Market cap $1.64BP/E 13.5Yield –
ANI Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
ANI Pharmaceuticals's EV/EBITDA was 6.3× on Nov 11, 2026, against 10.8× a year earlier. Over the last 5 years it ranged from 6.3× to 88.3×, with a median of 15.5×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.3× | −3.8 |
| 2025 | Dec 31, 2025 | 10.1× | −7.2 |
| 2024 | Dec 31, 2024 | 17.3× | +6.9 |
| 2023 | Dec 29, 2023 | 10.4× | −64.5 |
| 2022 | Apr 29, 2022 | 74.9× | +49.1 |
| 2021 | Dec 31, 2021 | 25.8× | +2.6 |
| 2020 | Dec 31, 2020 | 23.2× | +13.4 |
| 2019 | Dec 31, 2019 | 9.8× | +1.1 |
| 2018 | Dec 31, 2018 | 8.7× | −6.3 |
| 2017 | Dec 29, 2017 | 15.0× | −0.7 |
| 2016 | Dec 30, 2016 | 15.7× | +7.1 |
| 2015 | Dec 31, 2015 | 8.6× | – |
See a number that looks wrong?